Giuseppe Accogli - Baxter International President

BAX Stock  MXN 646.24  0.00  0.00%   

President

Mr. Giuseppe Accogli was appointed as Senior Vice President, President Global Businesses of the Company. Prior to his current role, Mr. Accogli served as Corporationrationrate Vice President and President, Renal from 2016 to 2017 and as Head of the U.S. region for Baxters Renal business from 2015 to 2016 since 2017.
Age 52
Tenure 7 years
Phone224 948 2000
Webhttps://www.baxter.com
Accogli joined Baxter in 2007 as Renal business unit Director in Italy, and assumed positions of increasing responsibility with the Renal business in Europe, including Head of the EMEA region for Renal from 2013 to 2015. Previously he worked as a Business Unit Manager and Sales and Marketing Manager for Medtronic and in several sales, product and marketing roles for Tyco and then Covidien in Italy and EMEA.

Baxter International Management Efficiency

The company has return on total asset (ROA) of 0.0375 % which means that it generated a profit of $0.0375 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3225) %, meaning that it generated substantial loss on money invested by shareholders. Baxter International's management efficiency ratios could be used to measure how well Baxter International manages its routine affairs as well as how well it operates its assets and liabilities.
Baxter International has accumulated 15.23 B in total debt with debt to equity ratio (D/E) of 62.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Baxter International has a current ratio of 1.79, which is within standard range for the sector. Debt can assist Baxter International until it has trouble settling it off, either with new capital or with free cash flow. So, Baxter International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Baxter International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Baxter to invest in growth at high rates of return. When we think about Baxter International's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 6 records

PRESIDENT Age

Sanjiv YajnikCapital One Financial
66
Robert TelesmanicCognizant Technology Solutions
56
Srinivasan VeeraraghavacharyCognizant Technology Solutions
63
James ClarkCVS Health
58
Andrew IaboniMcEwen Mining
41
Michael WassmerCapital One Financial
53
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois. Baxter International operates under Medical Instruments Supplies classification in Mexico and is traded on Mexico Stock Exchange. It employs 50000 people. Baxter International (BAX) is traded on Mexican Exchange in Mexico and employs 60,000 people.

Management Performance

Baxter International Leadership Team

Elected by the shareholders, the Baxter International's board of directors comprises two types of representatives: Baxter International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Baxter. The board's role is to monitor Baxter International's management team and ensure that shareholders' interests are well served. Baxter International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Baxter International's outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrew Frye, Senior Vice President and President APAC
Brian Stevens, Senior Vice President Chief Accounting Officer, Controller
David Rosenbloom, Sr Counsel
Giuseppe Accogli, Senior Vice President and Presidentident - Global Businesses
Clare Trachtman, Vice President Investor Relations
Stacey Eisen, VP Communications
Cristiano Franzi, Senior Vice President and President EMEA
Talvis Love, VP Officer
Jose Almeida, Chairman of the Board and Presidentident, CEO
James Saccaro, Corporate Vice President and CFO

Baxter Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Baxter International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Baxter Stock Analysis

When running Baxter International's price analysis, check to measure Baxter International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baxter International is operating at the current time. Most of Baxter International's value examination focuses on studying past and present price action to predict the probability of Baxter International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baxter International's price. Additionally, you may evaluate how the addition of Baxter International to your portfolios can decrease your overall portfolio volatility.